Francesco Lo Monaco: The Supplement You Take for Your Heart Could Be the One Increasing Your Risk of a Heart Attack
Francesco Lo Monaco, Cardiologist and Founder of The National Heart Clinic, posted on LinkedIn:
“The supplement you take for your heart could be the one increasing your risk of a heart attack.
People trying to do the right thing for their health… taking supplements they believe are protective…
and unintentionally increasing their cardiovascular risk instead.
Here’s what many don’t know:
- Calcium on its own.
High-dose calcium without vitamin D can do the opposite of what you expect, instead of strengthening your bones, it may harden your arteries.
Studies show up to a 30% higher risk of heart attack with calcium alone.
When vitamin D is added, that risk disappears. - Niacin (Vitamin B3)
Once seen as “heart-protective”, niacin in high doses can trigger inflammation inside blood vessels, doubling heart attack and stroke risk.
Ironically, it cancels out the very benefit it’s meant to give. - Fish Oil
If you already have heart disease, fish oil might help.
But if your heart is healthy, regular excessive use can increase the risk of irregular heartbeats. - Red Yeast Rice and ‘Natural’ Heart Supplements.
Many of these contain the same active compounds as prescription statins, without proper monitoring.
That means possible muscle damage, toxicity, or dangerous interactions if you’re already on medication.
My advice:
Supplements are good but they can have real effects, and sometimes, real risks.
Before starting anything, ask yourself:
→ Do I actually need this?
→ Is it based on my blood work and clinical context?
→ Am I combining it safely with other treatments?
Because prevention is powerful, but only when it’s personalised and guided by data.
If you’re investing in your health and longevity, make sure your supplements are helping, not silently harming.”

Stay updated with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch